- Taysha Gene Therapies granted inducement equity awards to four new employees under its 2023 Inducement Plan.
- Awards included restricted stock units covering 300,000 shares.
- Stock options covered 92,400 shares with an exercise price of $4.31.
- RSUs vest in four equal annual installments starting on first anniversary of vesting commencement date.
- Options vest over four years, with 25% vesting on first anniversary.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Taysha Gene Therapies Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202604030800PRIMZONEFULLFEED9683694) on April 03, 2026, and is solely responsible for the information contained therein.
Comments